Literature DB >> 16089243

Dextromethorphan-induced delirium and possible methadone interaction.

Francis E Lotrich1, Jules Rosen, Bruce G Pollock.   

Abstract

INTRODUCTION: Dextromethorphan is a commonly used antitussive agent that can be purchased over the counter. It is metabolized primarily by the cytochrome P450 (CYP) 2D6 isozyme. Methadone has been found to inhibit CYP2D6, indicating a potential for interaction with dextromethorphan. CASE
SUMMARY: An 83-year-old woman was evaluated for delirium, hypersomnia, confusion, lethargy, impaired concentration, and poor food intake. Symptoms resolved soon after discontinuing dextromethorphan. DISCUSSION: Vulnerability to delirium was potentially caused by coadministration of methadone, which can inhibit the CYP2D6 isozyme.
CONCLUSION: Evaluation of delirium should include close investigation of the patient's medications for potential interactions with dextromethorphan.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16089243     DOI: 10.1016/j.amjopharm.2005.03.002

Source DB:  PubMed          Journal:  Am J Geriatr Pharmacother        ISSN: 1876-7761


  2 in total

Review 1.  Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.

Authors:  Elinore F McCance-Katz; Lynn E Sullivan; Srikanth Nallani
Journal:  Am J Addict       Date:  2010 Jan-Feb

2.  A placebo-controlled trial of dextromethorphan as an adjunct in opioid-dependent patients undergoing methadone maintenance treatment.

Authors:  Sheng-Yu Lee; Shiou-Lan Chen; Yun-Hsuan Chang; Chun-Hsien Chu; Shih-Heng Chen; Po See Chen; San-Yuan Huang; Nian-Sheng Tzeng; Liang-Jen Wang; I Hui Lee; Tzu-Yun Wang; Kao Chin Chen; Yen Kuang Yang; Jau-Shyong Hong; Ru-Band Lu
Journal:  Int J Neuropsychopharmacol       Date:  2015-02-25       Impact factor: 5.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.